Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | BioXcel Therapeutics, Inc. | Wiley Matthew T.
(Chief Commercial Officer) |
S | Common Stock | D | 6272 | $0.55 - $0.55 | $3,449 |
| 2024-10-03 | BioXcel Therapeutics, Inc. | Rodriguez Javier
(See Remarks) |
S | Common Stock | D | 6863 | $0.55 - $0.55 | $3,774 |
| 2024-10-03 | BioXcel Therapeutics, Inc. | Yocca Frank
(Chief Scientific Officer) |
S | Common Stock | D | 7175 | $0.55 - $0.55 | $3,946 |
| 2024-10-03 | BioXcel Therapeutics, Inc. | Steinhart Richard I
(Chief Financial Officer) |
S | Common Stock | D | 7175 | $0.55 - $0.55 | $3,946 |
| 2024-10-03 | BioXcel Therapeutics, Inc. | O'Neill Vincent
(See Remarks) |
S | Common Stock | D | 5556 | $0.55 - $0.55 | $3,055 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | Yocca Frank
(Chief Scientific Officer) |
S | Common Stock | D | 355 | $0.69 - $0.69 | $244 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | Mehta Vimal
(CEO and President) |
S | Common Stock | D | 1982 | $0.69 - $0.69 | $1,366 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | Steinhart Richard I
(Chief Financial Officer) |
S | Common Stock | D | 356 | $0.69 - $0.69 | $245 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | Rodriguez Javier
(See Remarks) |
S | Common Stock | D | 345 | $0.69 - $0.69 | $238 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | O'Neill Vincent
(See Remarks) |
S | Common Stock | D | 138 | $0.69 - $0.69 | $95 |
| 2024-09-16 | BioXcel Therapeutics, Inc. | Wiley Matthew T.
(Chief Commercial Officer) |
S | Common Stock | D | 215 | $0.69 - $0.69 | $148 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | Yocca Frank
(Chief Scientific Officer) |
S | Common Stock | D | 372 | $1.28 - $1.28 | $476 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | Wiley Matthew T.
(Chief Commercial Officer) |
S | Common Stock | D | 244 | $1.26 - $1.26 | $308 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | Steinhart Richard I
(Chief Financial Officer) |
S | Common Stock | D | 372 | $1.26 - $1.26 | $469 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | Rodriguez Javier
(See Remarks) |
S | Common Stock | D | 361 | $1.26 - $1.26 | $456 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | O'Neill Vincent
(See Remarks) |
S | Common Stock | D | 155 | $1.28 - $1.28 | $199 |
| 2024-06-17 | BioXcel Therapeutics, Inc. | Mehta Vimal
(CEO and President) |
S | Common Stock | D | 2134 | $1.28 - $1.28 | $2,738 |
| 2024-06-04 | BioXcel Therapeutics, Inc. | BioXcel LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 252028 | $1.58 - $1.63 | $405,134 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |